Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
<< anterior 21 a 40 de 239 siguiente >>
Presentar resultados
Seleccionar todas
21.Enlace a cita originalTiene citas relacionadas
Bibbins-Domingo K, on behalf of the U.S. Preventive Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2016;164:836-45. [Ref.ID 100466]
22.Enlace a cita originalTiene citas relacionadas
Whitlock EP, Burda BU, Williams SB, Guirguis-Blake JM, Evans CV. Bleeding risks with aspirin use for primary prevention in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2016;164:826-35. [Ref.ID 100465]
23.Enlace a cita originalTiene citas relacionadas
Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DSM, Anderson ML. Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the U.S. Preventive Services Task Force. Ann Intern Med 2016;164:814-25. [Ref.ID 100464]
24.Enlace a cita originalTiene citas relacionadas
Guirguis-Blake JM, Evans CV, Senger CA, O'Connor EA, Whitlock EP. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2016;164:804-13. [Ref.ID 100463]
25.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dehmer SP, Maciosek MV, Flottemesch TJ, LaFrance AB, Whitlock EP. Aspirin for the primary prevention of cardiovascular disease and colorectal cancer: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2016;164:777-86. [Ref.ID 100462]
26. Cita con resumen
Chao TF, Liu CJ, Liao JN, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chen TJ, Lip GY, Chen SA. Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage. Circulation 2016;133:1540-7. [Ref.ID 100280]
27. Cita con resumen
Purrucker JC, Haas K, Rizos T, Khan S, Wolf M, Hennerici MG, Poli S, Kleinschnitz C, Steiner T, Heuschmann PU, Veltkamp R. Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants. JAMA Neurology 2016;73:febrero. [Ref.ID 99784]
29.Tiene citas relacionadas Cita con resumen
Shin J-Y, Park M-J, Lee SH, Choi S-H, Kim M-H, Choi N-K, Lee J, Park B-J. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ 2015;351:h3517. [Ref.ID 99249]
30. Cita con resumen
Kuramatsu JB, Gemer ST, Schellinger PD, Glahn J, Endres M, Sobesky J, Fleschsenhar J, Neugebauer H, Jüttler E, Grau A, Palm F, Röther J, Michels P, Hamann GF, Hüwel J, Hagemann G, Barber B, Terborg C, Trostdorf F, Bäzner H, Roth A, Wöhrle J, Keller M, Schwarz M, Reimann G, Volkmann J, Müllges W, Kraft P, Classen J, Hobohm C, Hom M, Milewski A, Reichmann H, Schneider H, Schimmel E, Fink GR, Dohmen C, Stetefeld H, Witte O, Günther A, Neumann-Haefelin T, Racs AE, Nueckel M, Erbguth F, Kloska SP, Dörfler A, Köhmann M, Schwab S, Huttner HB. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 2015;313:824-36. [Ref.ID 98820]
31. Cita con resumen
Hernández I, Baik SH, Piñera A, Zhang Y. Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med 2014;175:18-24. [Ref.ID 98701]
33.Tiene citas relacionadas Cita con resumen
Steinberg BA. Refined bleeding estimates in adults starting anticoagulants. BMJ 2014;349:g4800. [Ref.ID 98176]
34. Cita con resumen
Anónimo. Advertisement new blood thinner approved for select patients. DIA Daily 2014:9 de mayo. [Ref.ID 97577]
35. Cita con resumen
Husten L. Mixed results on Pradaxa from FDA. Journal Watch 2014:14 de mayo. [Ref.ID 97519]
36. Cita con resumen
Anónimo. FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients . U.S. Food and Drug Administration 2014:8 de mayo. [Ref.ID 97512]
37.Tiene citas relacionadas Cita con resumen
Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, Kunz A, Koch P, Kellner PA, Gierhake D, Villringer K, Fiebach JB, Grittner U, Hartmann A, Mackert BM, Endres M, Audebert HJ, for the STEMO consortium. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 2014;311:1622-31. [Ref.ID 97493]
38.Tiene citas relacionadas Cita con resumen
Grotta JC. tPA for stroke: important progress in achieving faster treatment. JAMA 2014;311:1615-7. [Ref.ID 97492]
39. Cita con resumen
Poll D, Antonucci E, Dentall F, Erba N, Testa S, Tiraferri E, Palareti G, on behalf of the Italian federation of anticoagulation clinics (FCSA). Recurrence of ICH after resumption of anticoagulation with VK antagonits. Neurology 2014;82:1020-6. [Ref.ID 97298]
40. Cita con resumen
Anónimo. Apixaban and rivaroxaban for stroke prevention in AF. Drug Ther Bull 2014;52:6-9. [Ref.ID 97113]
Seleccionar todas
 
<< anterior 21 a 40 de 239 siguiente >>